Keyphrases
Enhanced Recovery after Surgery (ERASĀ®)
100%
Recurrence-free Survival
50%
Enhanced Recovery
49%
Enhanced Recovery Program
46%
Non-small Cell Lung Cancer (NSCLC)
46%
Overall Survival
46%
Gynecologic Surgery
46%
Confidence Interval
41%
Analgesia
28%
Pulmonary Vein
28%
Long-term Survival
25%
Pain Management
24%
Length of Stay
24%
Systolic Anterior Motion of the Mitral Valve
23%
Spine Surgery
23%
Chronic Pain
23%
Postoperative Acute Kidney Injury
23%
Opioid Exposure
23%
Cancer Center
23%
Metastatic Testicular Cancer
23%
Lung Cancer Surgery
23%
Post-esophagectomy
23%
Conventional Management
23%
Exposure Control
23%
Pediatric Patients
23%
Lung Surgery
23%
Esophageal Cancer
23%
Congenital Toxoplasmosis
23%
Thoracic Epidural Analgesia
23%
Risk Factors
23%
Pathophysiology
23%
Mitigation Strategies
23%
Epidemiology
23%
Pairwise Comparison
23%
Risk Identification
23%
Acute Kidney Injury
23%
Hazard Ratio
23%
Patient Outcomes
23%
Short-term Outcomes
23%
Undergraduate Medical Education
23%
Survival Surgery
23%
Primary Familial Brain Calcification
23%
Health Care Costs
23%
Breast Cancer Survival
23%
Platelet-to-lymphocyte Ratio
23%
Paravertebral Block
23%
Readmission
23%
Long-term Sequelae
23%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
23%
Bariatric Surgery
23%
Medicine and Dentistry
Enhanced Recovery After Surgery
99%
Gynecological Surgery
46%
Pneumonectomy
38%
Perioperative Period
37%
Analgesia
36%
Pulmonary Vein
34%
Recurrence Free Survival
33%
Overall Survival
33%
Transesophageal Echocardiography
26%
Epidural Analgesia
25%
Metastatic Carcinoma
24%
Malignant Neoplasm
23%
Chronic Pain
23%
Platelet
23%
Lung Cancer
23%
Pediatrics Patient
23%
Breast Cancer Survival
23%
Orthostatic Hypotension
23%
Reoperation
23%
Spine Surgery
23%
Testis Cancer
23%
Bupivacaine
23%
Congenital Toxoplasmosis
23%
Lung Surgery
23%
Esophagectomy
23%
Esophageal Cancer
23%
Nonsteroid Antiinflammatory Agent
23%
Pathophysiology
23%
Health Care Cost
23%
Mitral Valve
23%
Bariatric Surgery
23%
Intercostal Nerve Block
23%
Left Atrium
23%
Acute Kidney Injury
23%
Cohort Effect
23%
Case Presentation
23%
Brain Calcification
23%
Lymphocyte
23%
Diseases
23%
Lung
19%
Surgery
19%
Postoperative Complication
19%
Breast Cancer
15%
Sequela
15%
Infection
15%
Neonatal Infant
15%
Hypotension
14%
Retrospective Study
14%
Hazard Ratio
13%
Cancer
12%